Iovance Biotherapeutics, Inc. (IOVA)
5.13
+0.55
(+12.01%)
USD |
NASDAQ |
Mar 06, 16:00
5.18
+0.05
(+0.97%)
After-Hours: 20:00
Iovance Biotherapeutics SG&A Expense (TTM) : 152.58M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Orthofix Medical, Inc. | 554.33M |
| InfuSystem Holdings, Inc. | 67.46M |
| Axogen, Inc. | 142.32M |
| KalVista Pharmaceuticals, Inc. | 160.68M |
| Lantheus Holdings, Inc. | 453.81M |